Welcome to Monday Morning Round-Up, featuring what’s new in health and medicine from around the web!
In the form of a wrist-worn band embedded with flexibile sensors and microprocessers, researchers at Stanford and the University of California Berkeley are unlocking the molecular insights from sweat that could diagnose cystic fibrosis, diabetes and other diseases.
Stalking the ‘Unknown Enemy’: Doctors Turn Scope On Rare Diseases via Kaiser Health News
The Undiagnosed Diseases Network was founded in 2015 with a $43 million grant from the National Institutes of Health (NIH). Building on work already being done at NIH, the initiative expanded to include universities across the country: Duke, Columbia and Stanford are among the other sites. The goals are to provide answers for patients with mysterious diseases and to learn more about the disorders.
Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy, according to new information from a large scale controlled clinical study. Cannabidiol is a molecule from the cannabis plant that does not have the psychoactive properties that create a ‘high.’
The Cost of Not Taking Your Medicine via The New York Times
Studies have consistently shown that 20 percent to 30 percent of medication prescriptions are never filled, and that approximately 50 percent of medications for chronic disease are not taken as prescribed. People who do take prescription medications — whether it’s for a simple infection or a life-threatening condition — typically take only about half the prescribed doses. This lack of adherence is estimated to cause approximately 125,000 deaths and at least 10 percent of hospitalizations, and to cost the American health care system between $100 billion and $289 billion a year.